Contrast Induced Nephropathy
43
2
2
25
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.0%
3 terminated out of 43 trials
89.3%
+2.8% vs benchmark
42%
18 trials in Phase 3/4
8%
2 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (43)
Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.
Supplementation With Beetroot Juice to Prevent Contrast Associated Nephropathy During Hospitalization for Acute Coronary Syndrome Without ST Elevation
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy
Contrast Nephropathy and Nitrates
Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure
Computed Tomography Arteriograms (CTA) Volume Dose Reduction Study
REduction of rIsk for Contrast Induced Nephropathy
A Maastricht Contrast-Induced Nephropathy Guidelines Study: CIN Prevention Guidelines: Appropriate & Cost-effective?
Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement
The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases
Renoprotective Effects of Fluid Prophylaxis Strategies for Contrast Induced Nephropathy (CIN)
Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial
Statins for Prevention of Contrast Induced Nephropathy
Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography
Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate
PREdictive Value of COntrast voluMe to creatinINe Clearance Ratio